Literature DB >> 11830183

Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study.

A Shekhar1, J S Katner, T J Sajdyk, R R Kohl.   

Abstract

Blockade of gamma-aminobutyric acid-A (GABA(A)) receptors in the dorsomedial hypothalamus (DMH) elicits a panic-like response that includes increases in heart rate (HR), blood pressure (BP), respiration rate (RR), and anxiety. Norepinephrine (NE) has been postulated to be critical in regulating panic and anxiety responses. Therefore, the first study sought to determine changes in extracellular NE levels within the DMH following acute blockade of GABA(A) receptors in the DMH using in vivo microdialysis. Rats were implanted with femoral arterial catheters and microdialysis probes into the DMH. Following recovery, the DMH of conscious rats were perfused with 100, 150, or 200 microM solutions of the GABA(A) receptor antagonist bicuculline methiodide (BMI) via the microdialysis probe. HR and BP responses were recorded and the changes in extracellular levels of NE in the dialysate samples from the DMH were determined by HPLC. Rats receiving BMI injections showed dose-dependent increases in both the extracellular NE levels in the DMH as well as HR and BP. The second study was conducted to test the functional importance of NE in the DMH to the BMI-induced physiological responses. The effects of BMI microinjection into the DMH were measured at baseline and 10 days after local injection of either vehicle or two doses of 6-hydroxydopamine (6-OHDA), a neurotoxin known to lesion NE terminals. There was a significant loss of tissue NE levels as well as BMI-induced HR, BP and RR responses in the 6-OHDA-treated but not vehicle-treated rats. Thus, blockade of GABA(A) receptors in the DMH results in NE release and the presence of NE appears to be necessary for eliciting the physiological components of the panic-like responses in this region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830183     DOI: 10.1016/s0091-3057(01)00688-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  A Genetically Encoded Fluorescent Sensor for Rapid and Specific In Vivo Detection of Norepinephrine.

Authors:  Jiesi Feng; Changmei Zhang; Julieta E Lischinsky; Miao Jing; Jingheng Zhou; Huan Wang; Yajun Zhang; Ao Dong; Zhaofa Wu; Hao Wu; Weiyu Chen; Peng Zhang; Jing Zou; S Andrew Hires; J Julius Zhu; Guohong Cui; Dayu Lin; Jiulin Du; Yulong Li
Journal:  Neuron       Date:  2019-03-25       Impact factor: 17.173

2.  Mapping cerebral blood flow changes during auditory-cued conditioned fear in the nontethered, nonrestrained rat.

Authors:  D P Holschneider; J Yang; T R Sadler; P T Nguyen; T K Givrad; J-M I Maarek
Journal:  Neuroimage       Date:  2005-10-10       Impact factor: 6.556

3.  Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis.

Authors:  Christopher E Stamper; Patrick A Hennessey; Matthew W Hale; Jodi L Lukkes; Nina C Donner; Kenneth R Lowe; Evan D Paul; Robert L Spencer; Kenneth J Renner; Miles Orchinik; Christopher A Lowry
Journal:  Stress       Date:  2015-02-17       Impact factor: 3.493

4.  Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Authors:  Paul J Gasser; Christopher A Lowry; Miles Orchinik
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

Review 5.  An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Authors:  Philip L Johnson; Anantha Shekhar
Journal:  Physiol Behav       Date:  2012-03-26

6.  Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses.

Authors:  Daniel E Rusyniak; Maria V Zaretskaia; Dmitry V Zaretsky; Joseph A DiMicco
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.